NCT02172625

Brief Summary

Nutrition supplementation with antioxidants have been discussed as a way to further enhance overall well-being of athletes, promote faster recovery, and improve overall performance. The use of Protandim, a nutritional supplement containing 5 botanicals (Bacopa extract 150 mg; milk thistle 225mg; ashwagandha 150 mg; green tea 75 mg; turmeric 75 mg) has shown promise in an earlier study by reducing oxidative stress and increasing the amount of the anti-oxidant enzymes in the blood. The purpose of this study was to examine the effect of \~90 day Protandim supplementation on 5-km running performance and on acute and long term oxidative damage as assessed by blood markers. Secondarily, another purpose of this study examined the effect of Protandim supplementation on other blood parameters (such as antioxidant enzyme concentrations) and measures of quality of life. The experiment was double-blind, placebo controlled. The study addressed two main questions and two secondary questions: Main Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) improve 5-km running times? Hypothesis: Protandim would improve 5-km running time by 0.5 min (SD 1-min). This is equivalent to an effect size of 0.5. The placebo group will have no change in performance. Main Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) reduce oxidative damage at rest as assessed by lipid peroxides (TBARS) in runners? Hypothesis: Based on the data by Nelson et al. (2006), oxidative damaged would be reduced by 40% (effect size = 4.8). Secondary Question 1: Does regular supplementation of Protandim (675 mg/day for 90 days) in runners reduce the increase in oxidative damage post-race compared to pre-race as assessed by lipid peroxides (TBARS)? Hypothesis: Based on the data by Kyparos et al. (2009), we expected a 45% increase in TBARS post-exercise compared to pre-exercise (effect size of 3.6). However, we expected that those that are on Protandim for 90 days will only have 31% increase in TBARS post-race (effect size = 2.5) \[based on changes in pre-post lipid peroxides from Arent et al. (2010)\]. Secondary Question 2: Does regular supplementation of Protandim (675 mg/day for 90 days) improve quality of life according to WHOQOL-BREF (Skevington, Lotfy, O'Connell, \& Group, 2004)? Hypothesis: There would be a statistical improvement in the quality of life post-Protandim supplementation which a small effect size improvement of 0.33.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2014

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
7 months until next milestone

Results Posted

Study results publicly available

January 9, 2017

Completed
Last Updated

February 12, 2019

Status Verified

January 1, 2019

Enrollment Period

7 months

First QC Date

June 20, 2014

Results QC Date

August 14, 2016

Last Update Submit

January 23, 2019

Conditions

Keywords

Athletic performanceRunningDietary supplementationQuality of lifeRunning performanceoxidative damage

Outcome Measures

Primary Outcomes (2)

  • 5-km Running Time

    5-km running performance time was measured twice at the beginning of the study, and then once post-supplementation. The best 5 km time from both initial sessions was counted as the baseline 5-km time. The full report can be found here: http://dx.doi.org/10.1371/journal.pone.0160559

    Baseline and 88 (SD 4) days

  • Lipid Peroxides (TBARS)

    Lipid peroxides (TBARS) is a measure of oxidative damage in the blood. The full report can be found here: http://dx.doi.org/10.1371/journal.pone.0160559

    Baseline, 30 days, 57 days, and 88 days

Secondary Outcomes (5)

  • Glutathione Peroxidase (GPX)

    Baseline, 30 days, 57 days, and 88 days

  • Quality of Life as Assessed by the World Health Organization Quality of Life Questionnaire (Brief)

    Baseline, 30 days, 57 days, and 88 days

  • Total Antioxidant Capacity (TAC)

    Baseline and 88 (SD 4) days. All pre-exercise values.

  • Whole Blood Glutathione Content (GSH)

    Baseline and 88 (SD 4) days. All pre-exercise values.

  • Superoxide Dismutase (SOD)

    Baseline, 30 days, 57 days, and 88 days

Study Arms (2)

Placebo Group

PLACEBO COMPARATOR

Corn starch and food coloring is the placebo comparator. Each subject will ingest 675 mg (1 pill) per day of the placebo comparator

Other: Placebo Group

Protandim Dietary Supplement

EXPERIMENTAL

Each subject will ingest 675 mg per day (1 pill) of Protandim for about 90 days. Each pill contains 5 botanicals (Bacopa extract 150 mg, milk thistle 225mg, ashwagandha 150 mg, green tea 75 mg, turmeric 75 mg).

Dietary Supplement: Protandim Dietary Supplement

Interventions

This was a randomized, block design, controlling for 5-km performance and sex. Subjects were given 675 mg per day (1 pill per day) of Protandim for 90 days. Subjects ran a 5-km time trial before and after the supplementation period. Blood samples were taken pre and post supplementation.

Also known as: Protandim Group, Experimental Group
Protandim Dietary Supplement

This was a randomized, block design, controlling for 5-km performance and sex. Subjects were given 675 mg per day (1 pill per day) of corn starch for 90 days. Subjects ran a 5-km time trial before and after the supplementation period. Blood samples were taken pre and post supplementation.

Also known as: Control Group
Placebo Group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy, non-pregnant subjects between 18 and 55 years of age. Apparently healthy is classified as A-1, A-2, or A-3 according to the American Heart Association
  • http://circ.ahajournals.org/content/97/22/2283/T6.expansion.html
  • Subjects have to achieve a classification of "local class" based on age-graded time USA Track \& Field. The age-graded time is the finish time adjusted to that of an open division participant using a factor for age and gender. Thus, the times for women and older participants are adjusted downward, while the times for most open division participants (such as 25-year-old men) remain the same. For example, a 55 year old woman has to run 29 minutes 45 seconds or better to be in the study:
  • http://www.usatf.org/statistics/calculators/agegrading/
  • For a man the same age, the equivalent time would be 25 minutes 2 seconds. This is approximately 60% of the speed of the current world record time for that age.
  • Subjects who will abstain from taking any nutritional supplements for the duration of the study, including vitamins and mineral supplements (Exception, ferrous sulfate, elemental iron, Vitamin D, Calcium). Subjects will also abstain from taking any over the counter products (herbals, melatonin, St. John's Wort, etc…) for the duration of the study.

You may not qualify if:

  • Under 18 and over 55 years of age; those who are not apparently healthy is classified as A-1, A-2, or A-3 according to the American Heart Association.
  • Subjects who are not able to run 5-km in the time required for their age and gender.
  • Subjects that will continue to take nutritional supplements, including over the counter products, for the duration of the study, including vitamins and mineral supplements (exception: Ferrous sulfate, Elemental iron, Vitamin D, Calcium).
  • Subjects that are taking prescription medications with the exception of birth control.
  • Known allergy or sensitivity to milk thistle, Bacopa monnieri, Ashwagandha, turmeric (or ginger), tea, its parts, caffeine, tannins, or members of the Theaceae family.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Crawford Gym, Room 17a, University of Louisville

Louisville, Kentucky, 40292, United States

Location

Related Publications (7)

  • Arent SM, Pellegrino JK, Williams CA, Difabio DA, Greenwood JC. Nutritional supplementation, performance, and oxidative stress in college soccer players. J Strength Cond Res. 2010 Apr;24(4):1117-24. doi: 10.1519/JSC.0b013e3181cb70b8.

    PMID: 20300015BACKGROUND
  • Kyparos A, Vrabas IS, Nikolaidis MG, Riganas CS, Kouretas D. Increased oxidative stress blood markers in well-trained rowers following two thousand-meter rowing ergometer race. J Strength Cond Res. 2009 Aug;23(5):1418-26. doi: 10.1519/JSC.0b013e3181a3cb97.

    PMID: 19620924BACKGROUND
  • Kabasakalis A, Kyparos A, Tsalis G, Loupos D, Pavlidou A, Kouretas D. Blood oxidative stress markers after ultramarathon swimming. J Strength Cond Res. 2011 Mar;25(3):805-11. doi: 10.1519/JSC.0b013e3181d0b109.

    PMID: 20613649BACKGROUND
  • Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med. 2006 Jan 15;40(2):341-7. doi: 10.1016/j.freeradbiomed.2005.08.043.

    PMID: 16413416BACKGROUND
  • Mullins AL, van Rosendal SP, Briskey DR, Fassett RG, Wilson GR, Coombes JS. Variability in oxidative stress biomarkers following a maximal exercise test. Biomarkers. 2013 Aug;18(5):446-54. doi: 10.3109/1354750X.2013.810668.

    PMID: 23862764BACKGROUND
  • Jeukendrup AE, Currell K. Should time trial performance be predicted from three serial time-to-exhaustion tests? Med Sci Sports Exerc. 2005 Oct;37(10):1820; author reply 1821. doi: 10.1249/01.mss.0000175095.56646.4b. No abstract available.

    PMID: 16260987BACKGROUND
  • Ueberschlag SL, Seay JR, Roberts AH, DeSpirito PC, Stith JM, Folz RJ, Carter KA, Weiss EP, Zavorsky GS. The Effect of Protandim(R) Supplementation on Athletic Performance and Oxidative Blood Markers in Runners. PLoS One. 2016 Aug 11;11(8):e0160559. doi: 10.1371/journal.pone.0160559. eCollection 2016.

Related Links

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Limitations and Caveats

* Serum TBARS to detect lipid peroxidation is not specific. * TBARS may have been measured too quickly post-exercise.

Results Point of Contact

Title
Dr. Gerald S. Zavorsky
Organization
Georgia State University

Study Officials

  • Gerald S Zavorsky, PhD

    University of Louisville

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 20, 2014

First Posted

June 24, 2014

Study Start

November 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2016

Last Updated

February 12, 2019

Results First Posted

January 9, 2017

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will share

The de-identified data is in SPSS format placed as a supplement in the published PLOS ONE article: http://dx.doi.org/10.1371/journal.pone.0160559

Locations